Navigation Links
On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
Date:2/19/2008

ne within Compendia and the only practical way to guarantee academic community access to these features was to take full responsibility for website support and data delivery."

"It was a big investment in both time and money, but it has always been critical to us that the academic communities have the same research capabilities as our corporate customers. We are proud that many of these new capabilities are still provided under a free research license," continued John Freshley. "Some advanced custom analyses require a license to Oncomine Research Premium Edition, but this modest investment is a tremendous value given the groundbreaking research that we and others have been able to accomplish using the premium features."

Along with expanded and new customer commitments, Compendia received an additional financial boost in 2007 when awarded a $2.4 million dollar SBIR Fast-Track award from the National Cancer Institute.

"This award was terrific validation of our approach and will allow us to truly scale the Oncomine platform in the future," said Dan Rhodes. "We have already completed the phase I feasibility portion of the award and are looking forward to rapidly executing the rest of the project."

About Compendia Bioscience, Inc.

Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes. http://www.compendiabio.com

About Oncomine(TM)

Oncomine(TM) combines a rapidly growing compendium of 24,000+ cancer transcriptome profiles with a sophisticated analysis engine and a powerful web application for data mining and visualization. Oncomine facilitates rapid and reliable biomarker and therapeutic target discovery, validation, and prioritization
'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 Vermillion, ... solutions company focused on gynecologic disease, announced today ... results before the market open on Wednesday, March ... and webcast at 8:30am Eastern. Conference Call & ... at 8:30am Eastern/5:30am Pacific Domestic: , 800-753-9057International: , ...
(Date:3/5/2015)... TUSTIN, Calif. , March 5, 2015  BioPhotas, ... energy products that use patented photo-therapeutic technologies to treat ... has partnered with the Semper Fi Fund to provide ... members in need of pain management solutions.  ... reported, "The first Marine who used the Celluma at ...
(Date:3/5/2015)... N.J. , March 5, 2015  Medical ... which specializes in high complexity, state-of-the-art, automated DNA-based ... new Human Papillomavirus (HPV) testing which utilizes cutting ... Each year, approximately 12,000 women are ... United States . Genital Human Papillomaviruses (HPV) ...
Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... Calif., Dec. 6, 2011 A new study ... clinics across the United States witnessed opiate prescriptions for ... 2008.  Dr. Michael Lowenstein, co-medical director for the Waismann ... , warns that this increase signals the gaining popularity ...
... a pioneer in the innovative treatment of extracorporeal ... that the first patient has been enrolled in ... of the company,s photopheresis technology in the treatment ... An estimated 15,000 new patients worldwide are diagnosed ...
Cached Medicine Technology:Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director 2Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director 3First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease 2First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease 3
(Date:3/6/2015)... “ Pokemini ” was featured on NewsWatch as part ... mobile applications on the iOS, Android, and Windows markets. Mallory ... the app review and shared with viewers how this is ... couple of years, mobile games have benefited from building in ... Crush allows users to connect their games to Facebook, see ...
(Date:3/6/2015)... Village, CO (PRWEB) March 06, 2015 ... infant mortality around the world is traveling to Angola, ... with survivors of their malnutrition program. , This will ... same region in Angola, demonstrating their commitment to the ... and under. The team will engage with the mothers ...
(Date:3/6/2015)... March 06, 2015 Ticket Down is a ... Oregon at the Moda Center. After being away ... Brooks is showing no signs of letting up on his ... legend and his wife, Trisha Yearwood, to venues around the ... bringing their critically acclaimed tour to the Moda Center in ...
(Date:3/6/2015)... March 06, 2015 Follow us ... the pharmacokinetics of a drug refers to testing of ... inside an organism. When toxicity studies are clubbed together ... or ADME/Tox. Increasing focus on lowering costs and time ... testing worldwide. The traditional drug development model uses toxicity ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... healthcare services programs, the organization has hired two new ... Ph.D. They will report to Grace Pavlath, Ph.D, ... President and Scientific Program Director, and together will lead ... to treatments and cures for various types of neuromuscular ...
Breaking Medicine News(10 mins):Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4
... health issues; company teams with fitness expert Denise Austin to launch ... ... living,longer and leading more active lives than their parents, yet still have,room ... by Energizer Holdings, Inc. (NYSE: ENR ), nearly two-thirds,(64 percent) of ...
... The Procter &,Gamble Company (NYSE: PG ) announced ... the quarter. Sales were up behind strong volume growth,from ... in developing regions. Organic volume increased six percent and,organic ... earnings per,share increased 17 percent to $0.98 per share, ...
... Education, KIRKLAND, Wash., Jan. 31 In ... want to keep. But these,seasoned people may leave ... taking,time off. Why? "A large percentage have aging ... needing constant attention," says Mario Sestito,Director of Business ...
... arthritis (RA), an inflammatory autoimmune disease, tend to ... One explanation for this increasingly recognized fact ... of inflammation, elevation of the C-reactive protein (CRP) ... the general population. However, other highly inflammatory ...
... build to dangerous levels in body and cause autism, ... -- The latest chapter in the debate over whether ... release of a study that showed the controversial mercury-containing ... can,t build up to toxic levels. , "Thimerosal has ...
... The Department of,Labor,s Occupational Safety and Health Administration ... are being accepted for,persons to serve on the ... committee was established under section 7(a) of the,Occupational ... the Secretary of Labor,and the Secretary of Health ...
Cached Medicine News:Health News:Boomers: Feeling Young or Fooling Themselves? 2Health News:Boomers: Feeling Young or Fooling Themselves? 3Health News:Boomers: Feeling Young or Fooling Themselves? 4Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 2Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 3Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 4Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 5Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 6Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 7Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 8Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 9Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 10Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 11Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 12Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 13Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 14Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 15Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 16Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 17Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 18Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 19Health News:Protecting Productivity at the Worksite in Challenging Times 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 3Health News:Mercury in Childhood Vaccines Excreted Quickly 2Health News:Mercury in Childhood Vaccines Excreted Quickly 3Health News:Mercury in Childhood Vaccines Excreted Quickly 4Health News:OSHA Seeking Nominations for National Advisory Committee on Occupational Safety and Health 2
... The Z-View Aberrometer is the first ... needs of the dispensing Eye Care Practitioner. ... pending) the Z-View Aberrometer quickly and accurately ... well as sphere, cylinder and axis to ...
... American Industrial Laboratories, Inc. specializes in ... eyebank and laboratory specular microscopes, digital ... camera digital upgrade package. Our software ... image data correlation with rapid image ...
... user friendly computerized medical record system whose ... productivity of the practice as well as ... It provides clinical templates for commonly presenting ... also contains an exhaustive database to cover ...
... The Z-1 applanation tonometer is ... 3Z slit lamp or most "Zeiss" ... provides highly accurate intra-ocular pressure readings. ... the slit lamp and the prism ...
Medicine Products: